T. Kern

Ophthalmology · 2004–2011

A researcher in the Science corpus: 3 papers; trusts 5 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom T. Kern trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. C. Serhan
  2. Rebecca Wall

Who trusts T. Kern overall

  1. Johnny Tang
  2. R. Goldberg

Papers from T. Kern's perspective

Ordered by how strongly the researchers T. Kern trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. (Annual Review of Immunology)
  2. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy (Nature Medicine)
  3. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease (Nature Medicine)
  4. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. (Nutrition reviews)
  5. Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes (New England Journal of Medicine)
  6. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice (Nature)
  7. A central role for inflammation in the pathogenesis of diabetic retinopathy (The FASEB Journal)
  8. Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema (Ophthalmology (Rochester, Minn.))
  9. Advanced glycation end products: sparking the development of diabetic vascular injury. (Circulation)
  10. Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy (International Journal of Experimental Diabetes Research)

Their papers